Survival benefit of pure dose-dense chemotherapy in breast cancer: a meta-analysis of randomized controlled trials.

about

Survival benefit of pure dose-dense chemotherapy in breast cancer: a meta-analysis of randomized controlled trials.

Item

http://www.wikidata.org/entity/Q55711832

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Survival benefit of pure dose- ...... randomized controlled trials.

@en

Survival benefit of pure dose- ...... randomized controlled trials.

@nl

type

Item

label

Survival benefit of pure dose- ...... randomized controlled trials.

@en

Survival benefit of pure dose- ...... randomized controlled trials.

@nl

prefLabel

Survival benefit of pure dose- ...... randomized controlled trials.

@en

Survival benefit of pure dose- ...... randomized controlled trials.

@nl

P1476

Survival benefit of pure dose- ...... f randomized controlled trials

@en

P2093

Faliang Xu

http://www.w3.org/2001/XMLSchema#string

Shizhe Chen

http://www.w3.org/2001/XMLSchema#string

Wenqi Zhou

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Bias in meta-analysis detected by a simple, graphical test

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Practical methods for incorporating summary time-to-event data into meta-analysis

Dose-dense therapy in the treatment of early-stage breast cancer: an overview of the data.

Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.

Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study.

Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.

SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer.

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

P2888

s12957-018-1424-4

P304

144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1186/S12957-018-1424-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xiaohua Zeng

P5008

ScienceSource

P577

2018-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1105598297

http://www.w3.org/2001/XMLSchema#string

P698

30007402

http://www.w3.org/2001/XMLSchema#string

P921

breast cancer

breast neoplasm

P932

6046095

http://www.w3.org/2001/XMLSchema#string